Ada Health secures $90m investment to enhance assessment tech

Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The investment will enable Ada to work towards becoming the world's leading personalised operating system for health, according to a statement from the digital health company. It will also be used to expand its offering in the United States. The Berlin-based digital health company received Series B investment from Leaps by Bayer, the investment arm of Bayer, as well as six other investors including Samsung. Ada Health provides an AI-based health assessment and care navigation platform to help patients better understand their symptoms and navigate the right care pathways at the right time.